Phantom Neuro, a neurotechnology company that offers a muscle-machine interface for controlling prosthetic limbs and robotic exoskeletons, announced an oversubscribed $19 million Series A funding round, bringing its total raise to $28 million.
Ottobock led the round with participation from existing investors Draper Associates, Time BioVentures, Breakout Ventures, Risk and Return, and LionBird...
